US Patent Issued to Regeneron Pharmaceuticals on June 3 for "IL2 agonists and methods of use thereof" (New York, New Jersey Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,724, issued on June 3, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"IL2 agonists and methods of use thereof" was invented by Jiaxi Wu (Elsmford, N.Y.), Tong Zhang (Fort Lee, N.J.), Maria del Pilar Molina-Portela (Bronx, N.Y.), Eric Smith (New York), Chia-Yang Lin (Scarsdale, N.Y.) and Thomas Craig Meagher (Yorktown Heights, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to IL2 agonists with improved therapeutic profiles."

The patent was filed on June 17, 2022, under Application No. 17/843,243.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov...